Replies to post #100289 on Savvy Trades and Investments

[hweb2]

CCEL not a low P/E. But I like it short-term for a quick scalp into that .90/share special dividend next week.

Longer-term, I think the risk/reward is very attractive in the $5's. Company cranks out steady profits, stock is way off its 52-week high of $14+, and I can see momo traders latching onto this stem cell play at some point. Plus CCEL has a few irons in the fire in the coming months. The Duke deal hasn't been reflected in the stock price at all imo. Check out the shareholder letter from my earlier post-

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168675248&txt2find=ccel